Stanley Druckenmiller's LLY Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 0 shares of Eli Lilly and Company (LLY) worth $0, representing 0.00% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Stanley Druckenmiller has maintained a strategic position in LLY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 252,830 shares. Largest reduction occurred in Q1 2024, reducing 340,886 shares.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | -100,675 | Sold Out | 0 | $0.00 |
| Q2 2025 | +5,845 | Add 6.16% | 100,675 | $779.53 |
| Q1 2025 | +32,640 | Add 52.48% | 94,830 | $825.91 |
| Q4 2024 | +62,190 | New Buy | 62,190 | $772.01 |
| Q2 2024 | -61,664 | Sold Out | 0 | $0.00 |
| Q1 2024 | -340,886 | Reduce 84.68% | 61,664 | $777.96 |
| Q4 2023 | -51,565 | Reduce 11.36% | 402,550 | $0.58 |
| Q3 2023 | -82,330 | Reduce 15.35% | 454,115 | $0.54 |
| Q2 2023 | -69,765 | Reduce 11.51% | 536,445 | $468.98 |
| Q1 2023 | -131,515 | Reduce 17.83% | 606,210 | $0.34 |
| Q4 2022 | +252,830 | Add 52.14% | 737,725 | $365.84 |
| Q3 2022 | +187,745 | Add 63.18% | 484,895 | $323.35 |
| Q2 2022 | +297,150 | New Buy | 297,150 | $324.23 |
Stanley Druckenmiller's Eli Lilly and Company Investment FAQs
Stanley Druckenmiller first purchased Eli Lilly and Company (LLY) in Q2 2022, acquiring 297,150 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Eli Lilly and Company (LLY) for 13 quarters since Q2 2022.
Stanley Druckenmiller's largest addition to Eli Lilly and Company (LLY) was in Q2 2022, adding 297,150 shares worth $96.34 M.
According to the latest 13F filing for Q3 2025, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 0 shares of Eli Lilly and Company (LLY), valued at approximately $0.
As of the Q3 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.00% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Eli Lilly and Company (LLY) was 737,725 shares, as reported at the end of Q4 2022.